Dave Meadows joined WCG in 2021 as President of the Scientific and Regulatory Review Division. In this role, he is responsible for the full range of global drug safety and pharmacovigilance services, including individual case safety reports, aggregate safety reporting, data monitoring committees, risk management, signal detection and regulatory safety reporting.
He brings extensive experience in supply chain management, process improvement and product line management: Before his move to WCG, Mr. Meadows held several roles at Thermo Fisher Scientific, most recently as Advanced Manufacturing and Engineering Lead in the Life Sciences Group, a segment he developed as well as led. He was also the VP/GM & President of Fisher Bioservices that supported Clinical Trials supply chain services, including cell & gene therapy packaging & labeling, as well as direct to patient clinical trials.
Prior to joining Thermo Fisher in 2007, Mr. Meadows held leadership roles with Procter & Gamble, Pall Corporation, and Delphi Automotive Systems.
He holds a BS and MS in Industrial Engineering from Lehigh University.